Global Proteinase K Market Report By Therapeutic Area (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Neurology, Others), By Form (Powder, Liquid) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2020-2027

ID:VMR11214810
April 2021
Report Formats:

Global Proteinase K Market Overview

The key driver impacting the proteinase K market is the growing incidence of chronic disorders. For instance, The National Center for Biotechnology Information (NCBI) report presents that almost one in three adults suffers from multiple chronic conditions (MCCs). The WHO report shows that chronic disease accounts for 60% of the worldwide disease burden in 2020. Globally cancer is responsible for the second most leading cause of death, and it accounted for 9.6 million deaths in 2018. Similarly, diabetes is also one of the most prevalent diseases globally. As per the International Diabetic Federation (IDF), In 2019, over 463 million adults (20-79 years) were living with diabetes, and it is likely to reach 700 million by 2045. Moreover, the growing applications of molecular diagnostic techniques and their associated enzymes for IVD contribute to the proteinase K's market growth in the coming years.

According to Value Market Research, the global proteinase K market size was valued at around USD 65 million in 2020 and is estimated to grow at a CAGR of about 7.5% during the forecast period 2021 to 2027.

The high utility of proteinase K in point of care (POC) diagnostic tests and pretreatment for efficient detection of COVID-19 are estimated to augment proteinase K in the forecast period. For example, it is used to pretreat sputum for the detection of SARS-CoV-2. Also, several benefits associated with the proteinase k enzyme lead to its high demand in point of care (POC) diagnostic tests. For example, it is a highly stable, highly reactive serine protease that can be used for several months when stored at 4 °C, thus creating a high demand for molecular diagnostics.  However, the reimbursement challenges associated with diagnostic tests and other proteases' availability may hamper the market in the long run. Also, challenges associated with the purification & recovery of enzymes negatively impact the market. The current industry trends, such as the rising applications scope in molecular biology and other fields and growing demand for gene therapy, are expected to offer new lucrative market opportunities for the key players.

The Proteinase K market is vast, with many local and global players. The Proteinase K market is extensive, with many regional and international players. The important market leaders follow numerous strategies to improve their market position, such as acquisitions, extending product portfolio, contracts, amalgamation, contracts, acquisitions, product upgrades to enlarge their market share across the globe. The significant players studied in the report include Merck KGaA, F. Hoffmann-La Roche Ltd, Advanced Enzymes Technologies Ltd, BBI Solutions, American Laboratories, Codexis, Inc., Amano Enzyme Inc., Biocatalysts Ltd, Amicogen, Dyadic International, Affymetrix, and American Laboratories.

Global Proteinase K Market Share

Know more about this report: Download free sample

In this research report, the Proteinase K market is segmented by therapeutic area, form, and region.

Analysis by Therapeutic Area:

By therapeutic area, the report is categorized into infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, neurology, and others. The Infectious Diseases segment dominates the therapeutic area segment with over 30.3% share in 2020. It is due to the wide applicability of proteinase K in the diagnosis of several infectious diseases. Moreover, the use of proteinase K results in the separation of the HBV genome from protein, which facilitates efficient isolation of DNA from the aqueous phase and contributes to the massive demand from the infectious disease segment in the forecast period.

Analysis by Form:

By Form, the report is categorized into Powder and Liquid. The core proteinase K services segment dominates the form segment with over 50% share in 2020. It is due to its high adoption as powdered formulation of proteinase K is advantageous as compared to the liquid one. Moreover, the increasing importance of such studies for targeted diagnosis and treatment leads to rising demand contributing to the Proteinase K powdered form segment growth in the forecast period.

Analysis by Region:

In the regional outlook of the global Proteinase K market, the North America region dominates globally with a 40% market share in the forecast period. It is due to the well-established healthcare infrastructure, an increase in investments by the public & private sectors in In Vitro Diagnostics (IVD). The initiatives like the Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT) program by National Human Genome Research Institute to screen infants for genetic diseases also add growth to the market. Moreover, the high adoption rate of molecular diagnostics and the presence of a substantial number of market players contribute to tremendous market growth across North America.

Market Segmentation covered in the Report:

By Therapeutic Area

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Neurology
  • Others

By Form

  • Powder
  • Liquid

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

METHODOLOGY

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.                

1. PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2. EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot

3. PROTEINASE K – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Therapeutic Area
           3.7.2 By Form
           3.7.3 By Region

4. VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5. IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis

6. GLOBAL PROTEINASE K MARKET ANALYSIS BY THERAPEUTIC AREA
       6.1 Overview by Therapeutic Area
       6.2 Historical and Forecast Data
       6.3 Analysis by Therapeutic Area
       6.4 Infectious Diseases Market by Regions
       6.6 Diabetes Market by Regions
       6.5 Oncology Market by Regions
       6.7 Cardiology Market by Regions
       6.8 Nephrology Market by Regions
       6.9 Autoimmune Diseases Market by Regions
       6.10. Neurology Market by Regions
       6.11 Others Market by Regions

7. GLOBAL PROTEINASE K MARKET ANALYSIS BY FORM
       7.1 Overview by Form
       7.2 Historical and Forecast Data
       7.3 Analysis by Form
       7.4 Powder Market by Regions
       7.5 Liquid Market by Regions

8. GLOBAL PROTEINASE K MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa

9. COMPETITIVE LANDSCAPE OF THE PROTEINASE K COMPANIES
       9.1. Proteinase K Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10. COMPANY PROFILES OF PROTEINASE K INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Merck KGaA
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. F. Hoffmann-La Roche Ltd
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Advanced Enzymes Technologies Ltd
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. BBI Solutions
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. American Laboratories
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Codexis, Inc.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Amano Enzyme Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Biocatalysts Ltd
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Amicogen
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Dyadic International
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Affymetrix
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. American Laboratories
           10.14.1. Company Overview
           10.14.2. Financials
           10.14.3. Products
           10.14.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • PreV/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Therapeutic Area (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Diabetes Market by Geography (USD MN)
  • Oncology Market by Geography (USD MN)
  • Cardiology Market by Geography (USD MN)
  • Nephrology Market by Geography (USD MN)
  • Autoimmune Diseases Market by Geography (USD MN)
  • Neurology Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Form (USD MN)
  • Powder Market by Geography (USD MN)
  • Liquid Market by Geography (USD MN)
  • Global Proteinase K Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Proteinase K Report
  • Market Research Process
  • Market Research Methodology
  • Global Proteinase K Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapeutic Area
  • Market Attractiveness Analysis by Form
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapeutic Area (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Diabetes Market by Geography (USD MN)
  • Oncology Market by Geography (USD MN)
  • Cardiology Market by Geography (USD MN)
  • Nephrology Market by Geography (USD MN)
  • Autoimmune Diseases Market by Geography (USD MN)
  • Neurology Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Form (USD MN)
  • Powder Market by Geography (USD MN)
  • Liquid Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials